Stakeholder engagement: Build trusted relationships with MOH decision‑makers, state health directors, hospital administrators, pharmacy and therapeutics (P&T) committees, clinical KOLs, and procurement units to shape access decisions and pathways.
Access strategy execution: Translate national access strategies into field action plans targeting MOH institutions; prioritize high‑impact accounts, indications, and pathways (formularies, tenders, pilot programmes, EPU procurement, APPL listings, etc.).
Policy and pathway navigation: Monitor MOH policies, budget cycles, HTA processes, and guideline updates; identify opportunities to align AZ value propositions with MOH priorities (NCD burden reduction, outcomes‑based care, cost containment).
Value communication: Deliver tailored value propositions (clinical, economic, and population‑health) using local data, burden‑of‑disease evidence, and budget impact models to support form...